English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Oncogenic human papillomavirus (HPV) infection is a main cause of cervical cancer. HIV-positive women are at an increased risk of becoming infected with high risk HPV (hrHPV) types that can lead to cervical cancer. Unlike other AIDS defining cancers, such as Kaposi’s sarcoma and Hodgkin’s lymphoma, the incidence of invasive cervical cancer among WLWHA has not decreased with the arrival of highly active antiretroviral therapies (HAART). [1,2] Annual Pap tests are recommended for WLWHA because the risk of developing cervical cancer, an AIDS defining illness, is increased in this group.[3] Early detection of abnormal, precancerous cells and following up on abnormal cytology results is essential to the prevention and control of cervical cancer among WLHWA.

infectious agents and cancer

Pap testing among newly diagnosed women living with HIV/AIDS (WLWHA) in South Carolina (SC): routine screening and abnormal follow-up behaviors of HIV-positive female SC medicaid recipients 18-64 years between 2005-2009